Kairoa is building a wearable sensing platform that turns real-world eating into continuous, objective measures for metabolic research and obesity drug development.
Capture meal timing, food context, chewing pace, pauses, meal duration and frequency, and within-meal slowing down, without relying on manual food logs or continuous user input.
Kairoa combines multi-modal physiological inputs to identify eating episodes and quantify meal dynamics continuously.
We extract precise eating topography capturing the exact structure of meals in free-living environments. Optional contextual sensing adds information about food and intake while reducing dependence on manual logging
Kairoa converts continuous physiological signals into the behavioral evidence that helps drug-development teams understand treatment response.
Passive, continuous capture of the movements that make up everyday eating.
Algorithms identify eating behavior while actively rejecting non-eating movement.
Episodes become interpretable measures for each meal and over time.
A behavioral measurement capability built to answer the questions that move a program forward.
Kairoa transforms episodic clinical snapshots into continuous behavioral trajectories, providing high-resolution visibility into how treatment (such as drug interventions) alter eating patterns and intake over time.
Robust measurement of eating behavior across diverse participants, foods, and real-world motion. Validated against video ground-truth.
Establishing repeatable, interpretable behavioral measures that are sensitive to defined treatment contexts and/or GLP-1 dose changes.
Executing sponsor-ready feasibility protocols and multi-day free-living pilots to unlock research answers for metabolic research and obesity drug development.
An interdisciplinary team with experience across deep tech, healthcare, and wearable systems.
Tell us about your metabolic health study. Kairoa's research-grade prototype is available for studies of weight gain, weight loss, and eating behavior.
Thank you. Our team will reach out shortly to discuss your study and prototype access.